MED · Medifast Inc
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-26 | Xian Ming |
Director |
Award↑
Filing footnotes — Restricted Stock Units (cash settled) (Direct)
Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on May 26, 2027. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock on the date of vesting. |
Restricted Stock Units (cash settled)
|
11,680 |
| 2026-05-26 | Geary Elizabeth A. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027. |
Common Stock
|
11,680 |
| 2026-05-26 | Kiai Parsa |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027. |
Common Stock
|
11,680 |
| 2026-05-26 | Rose Jeffrey Matthew |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027. |
Common Stock
|
11,680 |
| 2026-05-26 | Thomas Andrea B |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027. |
Common Stock
|
11,680 |
| 2026-05-26 | SCHLACKMAN SCOTT |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027. |
Common Stock
|
11,680 |
| 2026-05-26 | Kiai Parsa |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer. |
Common Stock
|
7,637 |
| 2026-05-26 | Rose Jeffrey Matthew |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer. |
Common Stock
|
6,739 |
| 2026-05-19 | Rose Jeffrey Matthew |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-05-11 | SCHLACKMAN SCOTT |
Director |
Buy↑
|
Common Stock
|
2,500 |
| 2026-05-08 | SCHLACKMAN SCOTT |
Director |
Buy↑
|
Common Stock
|
2,500 |
| 2026-03-25 | Maloney James P. |
Senior VP & CFO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
Common Stock
|
34,344 |
| 2026-03-25 | MacKenzie Jonathan Barrett |
VP, Finance & CAO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
862 |
| 2026-03-25 | Maloney James P. |
Senior VP & CFO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of common stock issued upon the vesting and settlement of performance stock units previously granted to the reporting person on March 17, 2023, which were earned based on achievement of performance criteria certified by the Compensation Committee on February 5, 2026. Each PSU represented a contingent right to receive one share of common stock. |
Common Stock
|
1,014 |
| 2026-03-25 | Chard Daniel R |
Director, Chairman & CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
Common Stock
|
36,968 |
| 2026-03-25 | MacKenzie Jonathan Barrett |
VP, Finance & CAO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
Common Stock
|
10,830 |
| 2026-03-25 | Maloney James P. |
Senior VP & CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
3,224 |
| 2026-03-25 | Chard Daniel R |
Director, Chairman & CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
20,095 |
| 2026-03-25 | Chard Daniel R |
Director, Chairman & CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of common stock issued upon the vesting and settlement of performance stock units previously granted to the reporting person on March 17, 2023, which were earned based on achievement of performance criteria certified by the Compensation Committee on February 5, 2026. Each PSU represented a contingent right to receive one share of common stock. |
Common Stock
|
4,827 |
| 2026-03-20 | Chard Daniel R |
Director, Chairman & CEO |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $10.04 to $10.18, inclusive. These shares are directly owned by a joint account of which the reporting person owns as a joint tenant with his spouse. |
Common Stock
(I)
|
17,678 |
| 2026-03-17 | Maloney James P. |
Senior VP & CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
482 |
| 2026-03-17 | Chard Daniel R |
Director, Chairman & CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
2,638 |
| 2026-03-17 | MacKenzie Jonathan Barrett |
VP, Finance & CAO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
70 |
| 2026-03-13 | Chard Daniel R |
Director, Chairman & CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
7,075 |
| 2026-03-13 | Maloney James P. |
Senior VP & CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
918 |
| 2026-03-13 | MacKenzie Jonathan Barrett |
VP, Finance & CAO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
198 |
| 2025-06-25 | BROWN JEFFREY J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026. |
Common Stock
|
11,167 |
| 2025-06-25 | Hoer Michael A. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026. |
Common Stock
|
11,168 |
| 2025-06-25 | Geary Elizabeth A. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026. |
Common Stock
|
11,168 |
| 2025-06-25 | Thomas Andrea B |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026. |
Common Stock
|
11,168 |
| 2025-06-25 | SCHLACKMAN SCOTT |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026. |
Common Stock
|
11,168 |
| 2025-06-25 | Xian Ming |
Director |
Award↑
Filing footnotes — Restricted Stock Units (cash settled) (Direct)
Represents the contingent right to receive shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"). These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Plan. |
Restricted Stock Units (cash settled)
|
11,167 |
| 2025-06-25 | Xian Ming |
Director |
Award↑
Filing footnotes — Restricted Stock Units (cash settled) (Direct)
The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Plan. The price per share of $13.39 is based on the 20-day moving average price of the Issuer's common stock as of June 6, 2025. |
Restricted Stock Units (cash settled)
|
6,013 |
| 2025-06-25 | BROWN JEFFREY J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer. The price per share of $13.39 is based on the 20-day moving average stock price of the Issuer's common stock as of June 6, 2025. |
Common Stock
|
9,449 |
| 2025-06-13 | Chard Daniel R |
Director, Chairman & CEO |
Buy↑
Filing footnotes — Common Stock (Indirect)
These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee. |
Common Stock
(I)
|
381 |
| 2025-03-25 | Chard Daniel R |
Director, Chairman & CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
Common Stock
|
124,953 |
| 2025-03-25 | MacKenzie Jonathan Barrett |
VP, Finance & CAO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
Common Stock
|
7,671 |
| 2025-03-25 | Maloney James P. |
Senior VP & CFO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
Common Stock
|
24,161 |
| 2025-03-17 | Maloney James P. |
Senior VP & CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
438 |
| 2025-03-17 | Chard Daniel R |
Director, Chairman & CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
1,864 |
| 2025-03-17 | MacKenzie Jonathan Barrett |
VP, Finance & CAO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
99 |
| 2025-03-16 | Maloney James P. |
Senior VP & CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
123 |
| 2025-03-16 | MacKenzie Jonathan Barrett |
VP, Finance & CAO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
60 |
| 2025-03-16 | Chard Daniel R |
Director, Chairman & CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
944 |
| 2025-03-13 | MacKenzie Jonathan Barrett |
VP, Finance & CAO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
280 |
| 2025-03-13 | Maloney James P. |
Senior VP & CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
835 |
| 2025-03-13 | Chard Daniel R |
Director, Chairman & CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
5,001 |
| 2024-09-13 | MacKenzie Jonathan Barrett |
VP, Finance & CAO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
Common Stock
|
11 |
| 2024-06-20 | Geary Elizabeth A. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
6,596 restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These awards are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025. |
Common Stock
|
6,596 |
| 2024-06-20 | Xian Ming |
Director |
Award↑
Filing footnotes — Restricted Stock Units (cash settled) (Direct)
Represents the contingent right to receive 10,149 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan. |
Restricted Stock Units (cash settled)
|
10,149 |